Glenmark Pharmaceuticals Limited
GLENMARK · NSE · ₹2,295 a share (close of 05 Oct 2026)
Available company data, source links and archived checks for Glenmark Pharmaceuticals Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue rose 23.1%; Net profit was ₹482.83 crore.
Quarter ended 2026-06-30 · consolidated · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Jun 2026 | Revenue: ₹4,018 cr | +23.1% | Net profit: ₹483 cr | +927.9% | 12.0% | Company filing source |
| Mar 2026 | Revenue: ₹3,771 cr | +15.8% | Net profit: ₹301 cr | +6773.2% | 8.0% | Company filing source |
| Dec 2025 | Revenue: ₹3,901 cr | — | Net profit: ₹403 cr | — | 10.3% | Company filing source |
| Sep 2025 | Revenue: ₹6,047 cr | — | Net profit: ₹610 cr | — | 10.1% | Company filing source |
| Jun 2025 | Revenue: ₹3,264 cr | +0.6% | Net profit: ₹47 cr | -86.2% | 1.4% | Company filing source |
| Mar 2025 | Revenue: ₹3,256 cr | — | Net profit: ₹4 cr | — | 0.1% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
SALDANHA FAMILY TRUST 45.4%HDFC MUTUAL FUND - HDFC MID-CAP FUND 6.2%GOVERNMENT PENSION FUND GLOBAL 3.9%AMANSA HOLDINGS PRIVATE LIMITED 2.2%INVESCO INDIA CONTRA FUND 2.2%register as filed
2026-06-30
Filing timeline — what the company told the exchange
- Glenmark Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2…
28 Sep 2026 · document
- Press Release. Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 23, 2026, titled "Glenmark Pharmaceuticals r…
23 Sep 2026 · document
- Analysts/Institutional Investor Meet/Con. Call Updates. Glenmark Pharmaceuticals Limited has informed the Exchange about Schedule of meet…
21 Sep 2026 · document
- Shareholders meeting. Glenmark Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 11, 2026. Fur…
11 Sep 2026 · document
- Press Release. Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 11, 2026, titled "Glenmark Expands Global Re…
11 Sep 2026 · document
- Glenmark Pharmaceuticals Limited has informed the Exchange about Credit Rating…
11 Sep 2026 · document
- Press Release. Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 21, 2026, titled "Glenmark Pharmaceuticals Inc.…
21 Aug 2026 · document
- Press Release. Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 20, 2026, titled "Glenmark Pharmaceuticals rece…
20 Aug 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time